Humacyte Receives U.S. Patent Covering Symvess and Other Bioengineered Tissues
The patent covers key aspects of how Symvess is manufactured, sterilized, stored and shipped, with coverage into 2043.
Related stories
Processa Pharmaceuticals Reports FDA Clearance for VT-7208 Phase 2 Study
Processa Pharmaceuticals reported FDA clearance for a Phase 2 study of VT-7208, a new pipeline collaboration and the appointment of Sheila Gujrathi as Executive Chair.
L impact | EQUITY | Oct 29, 2026, 12:53 PM UTC
AVIC Xi’an Aircraft Industry Group Q3 Net Profit Falls 48.93% Year Over Year
M impact | EQUITY | Oct 29, 2026, 12:53 PM UTC
ODNB Financial Corporation Reports Third-Quarter 2026 Results
M impact | EQUITY | Oct 29, 2026, 12:53 PM UTC
Xiamen Xiangyu Q3 Net Profit Falls 0.77% Year Over Year
M impact | EQUITY | Oct 29, 2026, 12:53 PM UTC
Otovo Completes Private Placement and Retail Share Offering at NOK 8 per Share
Otovo says it has completed a directed share issue and an offering to individuals at NOK 8 per share.
L impact | EQUITY | Oct 29, 2026, 12:52 PM UTC
Hershey shares fall about 2% premarket on Halloween spending warning
Hershey shares fell about 2% in premarket trading after the company warned of pressure on consumer spending ahead of Halloween.
M impact | EQUITY | Oct 29, 2026, 12:52 PM UTC